These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 30109593

  • 1. Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.
    Ko KY, Wang SY, Yen RF, Shiau YC, Hsu JC, Tsai HY, Lee CL, Chiu KM, Wu YW.
    J Nucl Cardiol; 2020 Feb; 27(1):269-279. PubMed ID: 30109593
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
    Tsai SY, Wu YW, Wang SY, Shiau YC, Chiu KM, Tsai HY, Lee CL, Hsu JC, Tu CM, Lin HH, Huang SH.
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2601-2609. PubMed ID: 31410543
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF, Oyen WJ.
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [Abstract] [Full Text] [Related]

  • 5. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2005 Jun; 5(16):1-167. PubMed ID: 23074467
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
    Mabuchi M, Kubo N, Morita K, Noriyasu K, Itoh Y, Katoh C, Kuge Y, Tamaki N.
    Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
    [Abstract] [Full Text] [Related]

  • 9. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
    Watanabe T, Okazaki O, Akutsu Y, Yamanaka H, Michihata T, Katagiri T, Harumi K.
    Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Takotsubo cardiomyopathy: FDG myocardial uptake pattern in fasting patients. Comparison of PET/CT, SPECT, and ECHO results.
    Kobylecka M, Budnik M, Kochanowski J, Piatkowski R, Chojnowski M, Fronczewska-Wieniawska K, Mazurek T, Maczewska J, Peller M, Opolski G, Krolicki L.
    J Nucl Cardiol; 2018 Aug; 25(4):1260-1270. PubMed ID: 28054182
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI].
    Büll U, Foroutan Y, Hellwig D, Kaiser HJ, Schulz G, Sabri O, Schreckenberger M, vom Dahl J.
    Nuklearmedizin; 1995 Dec; 34(6):223-8. PubMed ID: 8596738
    [Abstract] [Full Text] [Related]

  • 13. Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET.
    Nkoulou R, Pazhenkottil AP, Buechel RR, Husmann L, Valenta I, Herzog BA, Wolfrum M, Ghadri JR, Kaufmann PA.
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):913-21. PubMed ID: 20931288
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 18F-deoxyglucose and the assessment of myocardial viability.
    Schelbert HR.
    Semin Nucl Med; 2002 Jan; 32(1):60-9. PubMed ID: 11839071
    [Abstract] [Full Text] [Related]

  • 17. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, van Marwick S, Kunze KP, Meinicke A, Götze K, Kastrati A, Langwieser N, Ibrahim T, Nahrendorf M, Schwaiger M, Laugwitz KL.
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [Abstract] [Full Text] [Related]

  • 18. Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy.
    Isobe S, Ando A, Nanasato M, Nonokawa M, Izawa H, Sobue T, Hirai M, Ito K, Ishigaki T, Murohara T, Yokota M.
    Nucl Med Commun; 2003 Oct; 24(10):1071-80. PubMed ID: 14508163
    [Abstract] [Full Text] [Related]

  • 19. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders].
    Maes A, Nuyts J.
    Verh K Acad Geneeskd Belg; 1997 Oct; 59(3):133-60. PubMed ID: 9490915
    [Abstract] [Full Text] [Related]

  • 20. Experimental study on "ischemic memory" of myocardium with different ischemic degrees by 18F-FDG PET/CT.
    Li J, Zheng N, Zhang G, Bao B, Liu L, Hao L, Wang X.
    Ann Nucl Med; 2020 Jan; 34(1):24-30. PubMed ID: 31637598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.